Acetylsalicylic acid Recruiting Phase 4 Trials for Peripheral Arterial Disease (PAD) / Myocardial Infarction / Diabetes Mellitus (DM) Treatment

RecruitingTreatment4 IdentifierTitleDrugs
NCT02959606SAFE (Sarpogrelate Anplone in Femoro-popliteal Artery Intervention Efficacy) Study
NCT02548650Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus
NCT02545933Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor